Technical aspects in pancreaticoduodenectomy and therapeutic strategies for pancreatic cancer: History, current status, and future perspectives
Tomohide Hori a , ∗, Daiki Yasukawa b
a Department of Surgery, Shiga General Hospital, Moriyama 524-8524, Japan
b Department of Surgery, Shiga University of Medical Science, Otsu 520-2192, Japan
∗ Corresponding author.
E-mail address: horitomo55office@yahoo.co.jp (T. Hori).
Abstract：The incidence of pancreatic cancer (PC) has increased, and invasive ductal adenocarcinoma is the most common among PC patients [1]. Even in patients who receive radical treatments, namely chemotherapy and surgery, the five-year survival is only 2%-9% [1]. Currently, many physicians recognize that further developments in multidisciplinary therapy are crucial to overcome PC [1].
引用本文:
. [J]. Hepatobiliary Pancreat Dis Int, 2022, 21(6): 600-602.
Hori T, Yasukawa D. Technical aspects in pancreaticoduodenectomy and therapeutic strategies for pancreatic cancer: History, current status, and future perspectives. Hepatobiliary Pancreat Dis Int, 2022, 21(6): 600-602.
2022, Vol. 21 
